Paris, France and Camberley, UK – 29 June 2021 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual Report and Accounts (“Annual Report”) for the year ended 31 December 2020 has been published and uploaded to the Company’s website. The Annual Report has been posted
Visit PageNews and Events
Full year 2020 results and update on growth strategy
Transformational performance in 2020Continued strong demand for COVID-19 testing in 2021Strategy to deliver long-term growth through test, instrument, and geographic expansion in key areas, supplemented by M&A http://novacyt.com/wp-content/uploads/2021/06/Novacyt-full-year-2020-results-Final-ENGLISH.pdf
Visit PageRésultats de l’exercice 2020 et actualisation de la stratégie de croissance
Performance transformationnelle en 2020Maintien d’une forte demande pour le test COVID-19 en 2021Stratégie visant à assurer une croissance à long terme grâce à l’expansion des gammes de tests, de l’implantation des instruments et des zones géographiques clés, complétée par des fusions et acquisitions. http://novacyt.com/wp-content/uploads/2021/06/Novacyt-full-year-2020-results-FRENCH-FINAL.pdf
Visit Page